精确干预虚拟现实训练在帕金森病中的平衡和步行:剂量反应元分析
1Tongren University, Tongren, China.
Frontiers in neurology
|August 29, 2025
概括
虚拟现实训练显著改善了帕金森病患者的平衡. 最好的VRT参数包括短时间的会议和一致的每周频率,以获得最佳结果.
科学领域:
- 神经学
- 康复医学
- 生物医学工程
背景情况:
- 帕金森病 (PD) 严重影响平衡和步态.
- 虚拟现实培训 (VRT) 是一种潜在的治疗方法.
研究的目的:
- 系统地评估VRT对PD患者的平衡和步态的影响.
- 通过剂量反应分析来确定最佳VRT参数,以提供临床指导.
主要方法:
- 按照PRISMA指南进行随机对照试验 (RCT) 的系统审查和元分析.
- 在2025年3月15日之前发表的6个RCT数据库中搜索了涉及PD患者和VRT的RCT.
- 使用随机效应模型进行元分析和剂量反应分析.
主要成果:
- 包括32个RCT与547名参与者.
- VRT显著改善了平衡 (BBS:大规模杀伤性武器 = 3. 63, p < 0. 01).
- 在非亚洲地区,VRT并没有显著改善功能步态 (6MWT: p = 0.13),但效果大小达到MDIC.
结论:
- 在改善PD患者平衡方面,VRT是有效的.
- 确定了最佳VRT参数:每次 ≤20分钟,每周4-7次,持续4-7周 (共40次).
- 功能性步行改善表明区域差异和剂量特异性,较长的疗程可能对非亚洲人群有益.
更多相关视频
06:00A Rehabilitation Program of Exoskeleton-assisted Body Weight-Supported Treadmill Training with Non-immersive Virtual Reality for Stroke Patients
Published on: May 16, 2025
378
11:06A Human-machine-interface Integrating Low-cost Sensors with a Neuromuscular Electrical Stimulation System for Post-stroke Balance Rehabilitation
Published on: April 12, 2016
10.5K
相关概念视频
Parkinson's Disease: Treatment
376
Neurodegenerative disorders, such as Parkinson's Disease (PD), involve the gradual and irreversible destruction of neurons in particular brain areas. These disorders exhibit standard features like proteinopathies, selective vulnerability of some neurons, and an interaction of intrinsic properties, genetics, and environmental influences in neural injury.
Parkinson's Disease is primarily a result of the loss of dopaminergic neurons in the substantia nigra pars compacta. The cornerstone of...
Parkinson's Disease is primarily a result of the loss of dopaminergic neurons in the substantia nigra pars compacta. The cornerstone of...
376
Parkinson's Disease: Overview
702
Neurodegenerative disorders are progressive diseases that cause irreversible damage and loss to neurons in specific brain areas. Examples of these disorders include Parkinson's disease, Alzheimer's disease, Multiple Sclerosis (MS), and Amyotrophic Lateral Sclerosis (ALS). These disorders share characteristics such as proteinopathies, selective neuronal vulnerability, and a complex interplay between genetic and environmental factors. The primary therapeutic goal for these conditions is...
702
